
Personalis, Inc.
NASDAQ:PSNL
3.63 (USD) • At close March 14, 2025
Overzicht | Financiële gegevens
Bedrijfsnaam | Personalis, Inc. |
Symbool | PSNL |
Munteenheid | USD |
Prijs | 3.63 |
Beurswaarde | 320,395,779 |
Dividendpercentage | 0% |
52-weken bereik | 1.135 - 7.2 |
Industrie | Diagnostics & Research |
Sector | Healthcare |
CEO | Mr. Christopher M. Hall |
Website | https://www.personalis.com |
An error occurred while fetching data.
Over Personalis, Inc.
Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs. It offers NeXT Platform, which provides data analysis for tumor and its immune microenvironment, from a single limited tissue or plasma
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)